Back to Journals » Vascular Health and Risk Management » Volume 16

Review

Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects

       
Total article views   HTML views PDF downloads Totals
6,135 Dovepress* 5,194+ 1,304 6,498
PubMed Central* 941 317 1,258
Totals 6,135 1,621 7,756
*Since 7 October 2020

View citations on PubMed and Google Scholar